Prosecution Insights
Last updated: April 19, 2026

BEIJING INSTITUTE FOR STEM CELL AND REGENERATIVE MEDICINE

4 pending office actions

Portfolio Summary

4
Total Pending OAs
1
Final Rejections
3
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18029400 EGFR-TARGETING CHIMERIC ANTIGEN RECEPTOR AEDER, SEAN E 1642 Non-Final OA May 04, 2023
18031990 COMPOSITION AND METHOD FOR TRANSDIFFERENTIATING NON-NEURONAL CELLS INTO NEURONS WESTON, ALYSSA G 1633 Non-Final OA Apr 14, 2023
18028502 ACTIVATED PLURIPOTENT STEM CELL, AND PREPARATION METHOD THEREFOR AND USE THEREOF WILSON, MICHAEL C 1638 Final Rejection Mar 24, 2023
18021685 EXPANSION CULTURE MEDIUM AND CULTURE METHOD FOR NEURAL CELLS EBBINGHAUS, BRIANA NOEL 1632 Non-Final OA Feb 16, 2023

Managing BEIJING INSTITUTE FOR STEM CELL AND REGENERATIVE MEDICINE's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month